$100M sweet spot round size
Most of their 11 investments are in rounds between $70M and $105M
2019
Soleno Therapeutics, Inc. raised $129M on September 28, 2023
Investors: Perceptive Advisors, Woodline Partners LP, Adage Capital Management and Commodore Capital, LP
Immunic Therapeutics raised $60M on October 10, 2022
Investors: Great Point Partners, Logos Global Management, LP, RTW Investments, LP, The Invus Group, Parkman Healthcare Partners LLC, Vivo Capital and Commodore Capital, LP
Immunovant raised $75M on October 4, 2022
Investors: TCG X, Logos Global Management, LP and Commodore Capital, LP
Allakos Inc raised $150M on September 19, 2022
Investors: TCG X, Vivo Capital, Surveyor Capital, RTW Investments, LP, Logos Global Management, LP and Commodore Capital, LP
Undisclosed raised $100M on May 16, 2022
Investors: Soleus Capital Management, L.P., RA Capital Management, L.P. and Commodore Capital, LP
Third Harmonic Bio raised $105M on January 16, 2022
Investors: RA Capital Management, L.P., RTW Investments, LP, Ajax Health, General Atlantic and Commodore Capital, LP
Undisclosed raised $105M on July 13, 2021
Investors: Atlas Venture, Surveyor Capital, Logos Global Management, LP, RA Capital Management, L.P. and Commodore Capital, LP
- raised $80M on March 1, 2021
Investors: Point72 Asset Management, Vivo Capital, RA Capital Management, L.P., Surveyor Capital, Logos Global Management, LP, SNBL USA, Aspire Capital Partners, LLC and Commodore Capital, LP
Shoreline Biosciences, Inc. raised $43M on February 7, 2021
Investors: -, Stork Capital S.à.r.l., Gilead Capital LP, Logos Global Management, LP, Cormorant Capital and Commodore Capital, LP
Cogent Biosciences raised $104M on July 6, 2020
Investors: Logos Global Management, LP, Atlas Venture, Perceptive Advisors, RTW Investments, LP, OrbiMed Advisors, Samsara BioCapital and Commodore Capital, LP